Vivani Medical VANI Neuromodulation Division — Net Income Loss

Other segment segments

Similar metrics at other companies

LIVNNeuromodulation — Operating Income

$44.15M-15.7%

LIVNNeuromodulation — Net revenue

$151.79M+9.3%

HRMYRare Neurological Diseases — Net Income Loss

$32.49M-28.7%

BSXNeuromodulation — Net Sales

$318M+17.3%

PGCWealth Management Division — Net Income Loss

$5.56M+16.9%

MGEENon Regulated Energy — Net Income Loss

$6.27M+4.2%

Questions, answered.

What is Vivani Medical's neuromodulation division — net income loss?

Vivani Medical (VANI) reported neuromodulation division — net income loss of -$768K in Q1 2026.

How has Vivani Medical's neuromodulation division — net income loss changed year-over-year?

Vivani Medical's neuromodulation division — net income loss decreased by 9.7% year-over-year, from -$700K to -$768K.

What does neuromodulation division — net income loss mean?

This metric reflects the bottom-line profitability of the Neuromodulation Division after accounting for all revenues and expenses associated with the segment. It serves as a primary indicator of the division's financial health and its ability to generate earnings independently. A positive value indicates profitability, while a negative value signifies a net loss for the segment.